🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Alignment Healthcare president sells over $360k in company stock

Published 16/07/2024, 21:38
ALHC
-

In a recent transaction, Dawn Christine Maroney, President of Markets at Alignment Healthcare, Inc. (NASDAQ:ALHC), sold a significant number of shares in the company. The transactions, which took place on July 12th and 15th, involved the sale of 40,000 shares of common stock at prices ranging from $9.00 to $9.035 per share, totaling approximately $361,389.

On July 12th, Maroney sold 300 shares at a price of $9.00 each. Following this transaction, she then sold 39,700 shares on July 15th at a weighted average price of $9.035, with sales conducted in multiple transactions at prices between $8.89 and $9.21, as detailed in the footnotes of the filing.

After the completion of these sales, Maroney still retains a substantial amount of Alignment Healthcare stock, owning 1,916,097 shares directly. The transactions were reported to the Securities and Exchange Commission and are publicly disclosed for investors and market observers.

Alignment Healthcare, based in Orange, California, operates within the hospital and medical service plans industry and is incorporated in Delaware. The company's stock is traded on the NASDAQ exchange under the ticker symbol ALHC.

Investors often keep an eye on insider transactions like these for insights into executive perspectives on the company's value and future performance. However, it's important to note that insider sales can be motivated by various personal financial considerations and do not necessarily indicate a negative outlook on the company's part.

In other recent news, Alignment Healthcare has experienced significant developments. The company reported a 50% increase in health plan membership and a 43% rise in total revenue in the first quarter of 2024. Despite the adjusted EBITDA being negative, it outperformed expectations. The company is raising its full-year guidance and narrowing its adjusted EBITDA range, aiming for at least a 20% increase in health plan membership and margin expansion in 2025.

In addition, Alignment Healthcare amended its corporate charter to limit the liability of certain officers, aligning with Delaware state law. This amendment was approved by the company's stockholders during the annual meeting. BofA Securities and Piper Sandler have both upgraded Alignment Healthcare's stock, from Neutral to Buy and from Neutral to Overweight respectively. Both firms cited improved visibility into the company's margin progression as a reason for their upgrades.

These are the latest developments for the company, reflecting its commitment to comply with applicable laws and regulations, as well as its focus on improving margins and expanding membership.

InvestingPro Insights

As investors digest the news of Dawn Christine Maroney's recent stock sale, Alignment Healthcare, Inc. (NASDAQ:ALHC) presents a mixed financial picture according to the latest data and analysis from InvestingPro. While the company has experienced significant revenue growth over the last twelve months, with an increase of 31.76%, it is grappling with challenges that are reflected in its financial metrics and analyst outlooks.

One key metric that stands out is Alignment Healthcare's high Price / Book ratio, which at 14.41 as of the last twelve months, suggests that the stock may be valued richly in relation to the company’s book value. Additionally, an InvestingPro Tips analysis indicates that the company's Relative Strength Index (RSI) suggests the stock is in overbought territory, which could signal a potential retraction in price.

Despite strong returns over the last year, with a 67.85% price total return, analysts are cautious about the company's profitability. According to InvestingPro Tips, analysts do not anticipate Alignment Healthcare will be profitable this year, and the company has not been profitable over the last twelve months. This is underscored by a negative P/E Ratio of -11.79, indicating that the company is currently not generating earnings per share.

For investors seeking a more in-depth analysis, InvestingPro offers additional insights. There are 11 more InvestingPro Tips available, which could provide valuable context for understanding Alignment Healthcare's stock performance and future outlook. To explore these tips, investors can visit: https://www.investing.com/pro/ALHC and use the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.